Nechuta et al. (53) evaluated the late effects of post-diagnosis lifestyle factors in a prospective sample of 6,295 ER positive Stage I-III breast cancer survivors, for whom risk of late recurrence was of concern, in three pooled cohorts from Shanghai, China (one study) and the US (2 studies). The gene discussed is ESR1; the disease is breast carcinoma.